Source: International Congress 2018 – EUS-B and EBUS: optimal utilisation of the EBUS scope
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Bousema (Veldhoven, Netherlands), I. Huijbregts (Veldhoven, Netherlands), M. Van Dorp (Alkmaar, Netherlands), F. Hoeijmakers (Leiden, Netherlands), N. Barlo (Alkmaar, Netherlands), N. Claessens (Arnhem, Netherlands), A. Dingemans (Maastricht, Netherlands), W. Hanselaar (Rotterdam, Netherlands), R. Kortekaas (Rotterdam, Netherlands), J. Lardenoije (Arnhem, Netherlands), J. Maessen (Maastricht, Netherlands), H. Schreurs (Alkmaar, Netherlands), M. Youssef-El Soud (Veldhoven, Netherlands), J. Annema (Amsterdam, Netherlands), F. Van Den Broek (Veldhoven, Netherlands). Guideline adherence and quality of (minimal) invasive mediastinal staging of NSCLC. 406

Member's Comments

No comment yet.

Related content which might interest you: Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0. Source: International Congress 2019 – General thoracic surgery Year: 2019 Impact on invasive mediastinal staging Source: Annual Congress 2004 - Impact of neoadjuvant treatments on morbidity and oncological outcome of patients with NSCLC Year: 2004 Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC. Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020 Is mediastinoscopy necessary in patients with negative EBUS-TBNA – A challenge to the ESTS Guidelines for staging of lung cancer Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007 Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Complete and systematic mediastinal nodal staging for lung cancer (SCORE study)> Source: International Congress 2017 – Interventional pulmonology highlights 2017 Year: 2017 Evaluation of the clinical utility of EBUS-TBNA sampling with ROSE (Rapid On-Site Evaluation) in the diagnosis of mediastinal and hilar metastatic non-lung extrathoracic primary carcinoma Source: Virtual Congress 2021 – Convex probe endobronchial ultrasound and radial probe endobronchial ultrasound Year: 2021 Diagnostic yield, clinical impact and cost aspect of EBUS-TBNA in mediastinal staging in lung cancer Source: Annual Congress 2012 - Progress in endoscopy for lung cancer Year: 2012 Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007 Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Implementation of EUS-FNA for lung cancer staging Source: Eur Respir J 2007; 30: Suppl. 51, 109s Year: 2007 Relationship of T status and metastasis according to new clinical TNM staging in non small cell lung carcinoma Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 The influence of nodal size on EUS-FNA outcomes for mediastinal staging of NSCLC Source: Annual Congress 2010 - Are needles enough: the value of different approaches Year: 2010 Mediastinal lymph node staging with spiral CT and FDG-PET in patients with non-small cell lung cancer (NSCLC). Avoidable thoracotomies Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging Year: 2004 Accuracy of re-mediastinoscopy and fusion PET-CT in the assessment of lymph node (LN) downstaging after induction chemotherapy for N2 non-small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 602s Year: 2006 Use of M.E.S.S.I.A. software in mediastinal staging of NSCLC Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017 Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Combined endobronchial and esophageal endosonography for mediastinal staging in lung cancer: Systematic review and meta-analysis Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015